INS and type 1 diabetes mellitus: Consequently, some medicines have been indagated as an additional treatment for T1DM, yet the Food and Drug Administration (FDA) only permitted pramlintide in 2005, which imitates a β-cell hormone that is co-secreted with insulin in the post-cibum time (10).